𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis

✍ Scribed by George V. Papatheodoridis; John Goulis; Gioacchino Leandro; David Patch; Andrew K. Burroughs


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
136 KB
Volume
30
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Endoscopic treatment (ET) is frequently used to prevent variceal rebleeding but this still occurs in about 50% of patients. Recently, transjugular intrahepatic portosystemic shunt (TIPS) has been compared with ET in several trials. Using a meta-analysis, we evaluated randomized trials comparing TIPS to ET assessing prevention of rebleeding, survival, and the effects on resource use and the quality of patients' lives. Medical databases were searched between January 1988 and January 1999 as well as published citations and conference proceedings. Sensitivity analyses for type of publication, methodological quality score, mean duration of follow-up, type of ET, etiology, and severity of liver disease were performed. Eleven randomized trials involving 811 patients fulfilled the selection criteria. The median follow-up ranged from 10 to 32 months. Variceal rebleeding was significantly more frequent with ET (47%) compared with TIPS (19%) (odds ratio [OR], 3.8; 95% confidence interval [CI], 2.8-5.2; P F .001), but there was no difference in mortality (OR, 0.97; 95% CI, 0.71-1.34). Post-treatment encephalopathy occurred significantly less often after ET (19%) than after TIPS (34%) (OR, 0.43; 95% CI, 0.30-0.60; P F .001). In the studies showing resource use this was more extensive for TIPS. The sensitivity analyses did not alter the main conclusion, and sole comparison with endoscopic ligation did not alter these results. In conclusion, in patients with variceal bleeding, TIPS compared with ET reduces the rebleeding rate, but does not improve survival, and increases the incidence of encephalopathy in a period of 1 to 2.5 years. Thus, TIPS cannot be recommended as the first choice treatment for prevention of variceal rebleeding. (HEPATOLOGY 1999;30:612-622.)

Variceal bleeding is one of the most frequent and severe complications of portal hypertension. 1 It is associated with a high mortality during the acute episode and a high rate of recurrence in the patients who survive. 2 Thus, many studies Abbreviations: ET, endoscopic treatment; TIPS, transjugular intrahepatic portosystemic shunt; OR, odds ratio; CI, confidence interval; NNT, number needed to treat.


πŸ“œ SIMILAR VOLUMES


A randomized trial comparing transjugula
✍ R Jalan; E H Forrest; A J Stanley; D N Redhead; J Forbes; J F Dillon; A J MacGil πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 204 KB πŸ‘ 2 views

The aim of this study was to compare transjugular intrahepatic portosystemic stent-shunt (TIPSS) with variceal band ligation (VBL) in the secondary prophylaxis of esophageal variceal hemorrhage in patients with cirrhosis. Fifty-eight patients with cirrhosis who presented with the first episode of es

Cost-effectiveness analysis of transjugu
✍ Mark W. Russo; Steven L. Zacks; Robert S. Sandler; Robert S. Brown Jr. πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

For the prevention of recurrent esophageal variceal bleeding, studies show that patients treated with transjugular intrahepatic portosystemic shunt (TIPS) have lower rebleeding rates compared with endoscopic therapy. However, TIPS is associated with higher rates of portosystemic encephalopathy and p

Transjugular intrahepatic portosystemic
✍ Manuela Merli; Francesco Salerno; Oliviero Riggio; Roberto de Franchis; Franco F πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 89 KB

## Transjugular intrahepatic portosystemic shunt (TIPS), a new technique for the treatment of portal hypertension, has been successful in preliminary studies to treat acute variceal hemorrhage and to prevent variceal rebleeding. The purpose of this multicenter, randomized controlled trial is to co

Transjugular intrahepatic portosystemic
✍ Jonathan A. Schneider; Edward A. White; Derek C. Welch; LeAnn S. Stokes; David S πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 200 KB

A 64-year-old man with portal hypertension secondary to hepatic nodular transformation was awaiting liver transplantation when he presented with severe, unrelenting abdominal pain, fever, and hypotension. Computed tomographyrevealed pneumatosis within the cecum and ascending colon. Because of his ad